| Title | Consultation response to the Medicines and Healthcare Products Regulatory Agency (MHRA) on 'Public consultation MLX 337 - Proposals to restrict the availability of medicines containing pseudoephedrine and ephedrine by a change of legal status from pharmacy (P) to prescription only (POM) together with a restriction on pack size' |